208 related articles for article (PubMed ID: 30206415)
21. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
22. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.
Lyapichev KA; Piña-Oviedo S; Medeiros LJ; Evans MG; Liu H; Miranda AR; Hunt KK; Clemens MW; Stewart JM; Amin MB; Quesada AE; Chai SM; Di Napoli A; Yoga A; Dave SK; Wistuba II; Wu Y; Bueso-Ramos CE; Schlette EJ; Ferrufino-Schmidt MC; Loghavi S; Khoury JD; Young KH; Miranda RN
Mod Pathol; 2020 Mar; 33(3):367-379. PubMed ID: 31383966
[TBL] [Abstract][Full Text] [Related]
23. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder.
Roden AC; Macon WR; Keeney GL; Myers JL; Feldman AL; Dogan A
Mod Pathol; 2008 Apr; 21(4):455-63. PubMed ID: 18223553
[TBL] [Abstract][Full Text] [Related]
24. T-cell Lymphomas: Updates in Biology and Diagnosis.
Ondrejka SL; Hsi ED
Surg Pathol Clin; 2016 Mar; 9(1):131-41. PubMed ID: 26940273
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of peripheral T-cell lymphomas.
O'leary H; Savage KJ
Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
[TBL] [Abstract][Full Text] [Related]
26. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
27. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.
Feldman AL; Law ME; Inwards DJ; Dogan A; McClure RF; Macon WR
Mod Pathol; 2010 Apr; 23(4):593-602. PubMed ID: 20118907
[TBL] [Abstract][Full Text] [Related]
28. Breast Implant-Associated Anaplastic Large Cell lymphoma: Brief overview of current data and imaging findings.
Collado-Mesa F; Yepes MM; Net JM; Jorda M
Breast Dis; 2021; 40(1):17-23. PubMed ID: 33554880
[TBL] [Abstract][Full Text] [Related]
29. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Oishi N; Miranda RN; Feldman AL
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma.
Oishi N; Hundal T; Phillips JL; Dasari S; Hu G; Viswanatha DS; He R; Mai M; Jacobs HK; Ahmed NH; Syrbu SI; Salama Y; Chapman JR; Vega F; Sidhu J; Bennani NN; Epstein AL; Medeiros JL; Clemens MW; Miranda RN; Feldman AL
Haematologica; 2021 Jun; 106(6):1714-1724. PubMed ID: 32414854
[TBL] [Abstract][Full Text] [Related]
31. Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations.
Costello R; Sanchez C; Le Treut T; Rihet P; Imbert J; Sébahoun G
Br J Haematol; 2010 Jul; 150(1):21-7. PubMed ID: 19912218
[TBL] [Abstract][Full Text] [Related]
32. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
33. FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype.
Ferreira CR; Zhao S; Sahoo MK; Pinsky B; Weber J; Lage LAPC; Pereira J; Zerbini MCN; Natkunam Y
Hum Pathol; 2018 Oct; 80():138-144. PubMed ID: 29898383
[TBL] [Abstract][Full Text] [Related]
34. Breast implant-associated anaplastic large cell lymphoma and other rare T-cell lymphomas.
de Leval L
Hematol Oncol; 2019 Jun; 37 Suppl 1():24-29. PubMed ID: 31187524
[No Abstract] [Full Text] [Related]
35. The First Confirmed Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Hawai'i.
Yim N; Parsa F; Faringer P
Hawaii J Health Soc Welf; 2019 Nov; 78(11):338-340. PubMed ID: 31723941
[TBL] [Abstract][Full Text] [Related]
36. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
37. B-cell lymphomas associated with breast implants: Report of three cases and review of the literature.
Evans MG; Miranda RN; Young PA; Pai L; Wang HY; Konoplev SN; Medeiros LJ; Pinter-Brown LC
Ann Diagn Pathol; 2020 Jun; 46():151512. PubMed ID: 32315816
[TBL] [Abstract][Full Text] [Related]
38. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
39. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
40. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Rondón-Lagos M; Rangel N; Camargo-Villalba G; Forero-Castro M
Eur J Surg Oncol; 2021 May; 47(5):942-951. PubMed ID: 33158639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
